NEW

Canon Medical Announces New Aquilion Exceed LB CT System

An estimated 1.8 million new cancer cases will be diagnosed in the U.S. this year alone, according to the American Cancer Society. With a disease so prevalent, treatments like radiation therapy are critical, and while planning, clinicians require accuracy, precision...

Bracco Diagnostics Inc. Introduces New CardioGen-82 Infusion System

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., has announced the FDA approval of its new CardioGen-82 infusion system to enhance automation, efficiency and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging...

Health Network Places $11 Million Order

GE Healthcare has announced its largest ever ultrasound deal in the United States – an $11 million order by St. Luke’s University Health Network to install GE Healthcare ultrasound technology and IT workflow solutions system-wide. GE Healthcare will continue upgrades...

Aidoc Granted AI Industry-First FDA Clearance for Triage of Incidental Pulmonary Embolism

Aidoc has announced that the U.S. Food and Drug Administration (FDA) has given regulatory clearance for the commercial use of its triaging and notification algorithms for flagging and communicating incidental pulmonary embolism. Flagging incidental, critical findings...

Flywheel, AIQ Solutions Partner to Improve Understanding of Treatment Response

Flywheel and AIQ Solutions recently announced a partnership to offer a data management and analysis solution to increase clinicians’ and researchers’ understanding of treatment response for complex diseases that include the largest research area of oncology. The combination of Flywheel’s cloud-scale data management and collaboration platform along with the powerful AIQ technology will provide a scalable solution for improved patient management and the overall delivery of accurate data for the therapeutic area.

With Flywheel’s strengths in data ingestion, curation and collaboration and AIQ’s advanced algorithms, physicians and researchers can more quickly determine optimal treatment plans for their patients and ultimately improve patient outcomes.

“Flywheel is excited about the partnership with AIQ as we work together to help clinicians, life sciences companies, and researchers access and share data and analysis that improves the quality and effectiveness of care they can provide to their patients,” says Jim Olson, CEO of Flywheel. “Together, Flywheel and AIQ will offer an integrated technology system unlike anything else available. We look forward to working together to help our customers make better therapy development and patient care decisions,” added Eric Horler, CEO of AIQ.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *